Viewing Study NCT03024034


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-02-22 @ 4:13 AM
Study NCT ID: NCT03024034
Status: COMPLETED
Last Update Posted: 2021-12-13
First Post: 2017-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 TP-271 Oral PK Single Ascending Dose Study
Sponsor: Tetraphase Pharmaceuticals, Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: TP-271-003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View